Edgewise’s Sevasemten Shows Positive Two-Year Results in Becker Muscular Dystrophy Trial

Edgewise Therapeutics, Inc. (Nasdaq: EWTX), a prominent biopharmaceutical company specializing in muscle diseases, has unveiled encouraging two-year topline results from the ARCH trial. The ARCH study, conducted at a single center, is an open-label investigation focusing on assessing safety, tolerability,…

Read MoreEdgewise’s Sevasemten Shows Positive Two-Year Results in Becker Muscular Dystrophy Trial

CND Life Sciences Showcasing Skin Biopsy Diagnostic Tool for Parkinson’s Disease at AAN 2024

CND Life Sciences (CND) has made a significant announcement regarding the presentation of six abstracts related to the identification of phosphorylated alpha-synuclein (P-SYN) in cutaneous nerve fibers in the skin at the American Academy of Neurology 2024 Annual Meeting (AAN).…

Read MoreCND Life Sciences Showcasing Skin Biopsy Diagnostic Tool for Parkinson’s Disease at AAN 2024

Antech Unveils AI Radiology and Cancer Screening for Veterinary Diagnostics

Antech, a leading veterinary diagnostics company dedicated to collaborating with veterinary professionals in predicting, diagnosing, and monitoring wellness and disease, has introduced two groundbreaking innovations that signify a new era in veterinary diagnostics. These innovations, AIS RapidRead for accelerated radiograph…

Read MoreAntech Unveils AI Radiology and Cancer Screening for Veterinary Diagnostics